Summary
Updated Aug 30, 2026
Michael Sardano is PRESIDENT AND GENERAL COUNSEL of Sensus Healthcare, Inc. (SRTS). 5 SEC Form 4 filings on record going back to 2024, most recently on 16 December 2025. Most recent open-market trade: bought $4K of SRTS on 19 November 2025. Lifetime open-market purchases: $11K. Historical track record: 1/5 stars across 3 tracked purchases.
Recent Transactions
5Every recent SEC Form 4 transaction Michael Sardano has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 0% |
| 90-day win rate | 67% |
| Avg 5-day return | -2.98% |
| Avg 30-day return | -6.52% |
| Avg 90-day return | +11.51% |
| Best 30-day return | -4.95% |
Trading Pattern
InsiderAlpha's records for Michael Sardano go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $4K (3 buys totaling $11K). The largest single buy on record is $4K of SRTS in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Sardano files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric Sachetta - $329K of SRTS open-market activity in the last 12 months
- Joseph C. Sardano - $161K of SRTS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michael Sardano?
Michael Sardano is a corporate insider, tracked as PRESIDENT AND GENERAL COUNSEL of Sensus Healthcare, Inc. (SRTS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Michael Sardano last file a Form 4?
The most recent primary Form 4 on record is dated 16 December 2025, one of 5 filings going back to 2024.
Has Michael Sardano been buying or selling stock?
Recorded transactions: 3 open-market purchases ($11K) and 0 open-market sales across all tracked filings.
How accurate is Michael Sardano's historical track record?
Across 3 tracked purchases, Michael Sardano averaged -6.5% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Michael Sardano's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michael Sardano and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial